Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2013 Oct 25;2(5):e000338. doi: 10.1161/JAHA.113.000338

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2013 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMC Copyright notice

Figure 5. — Reduction of scar size (POSEIDON clinical trial). (Left) MDCT 3D reconstruction image with (Right) respective (A) basal and (B) midventricular short axis images of a patient with chronic ischemic cardiomyopathy with a scar size (MDCT‐EED outlined in red) of (A and B) 40.34 g and its reduction to (A' and B') 26.35 g after transendocardial stem cell injection (TESI) with allogeneic MSCs (100 million). EED indicates early enhancement defect; MDCT, multi‐detector computer tomography; MSCs, mesenchymal stem cells; POSEIDON, PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis.